The Ethical, Legal, and Regulatory Issues Associated with Pharmacogenomics

Miao, Liyan; Zhang, Jingjing; Yi, Ling Xing; Huang, Shenjia

doi:10.1007/978-981-15-3895-7_12

Cited by 2 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given genetic information's personal and sensitive nature, patients must be fully informed about the purpose, risks, and potential implications of genetic testing before they decide to undergo such testing. The complexity of genomic data and the potential for incidental findings require a comprehensive and understandable disclosure process (Master, Smith, & Tilburt, 2020;Miao, Zhang, Yi, & Huang, 2020). Healthcare professionals, including pharmacists, play a crucial role in ensuring that patients comprehend the nuances of pharmacogenomic testing.…”

Section: Ethical and Legal Considerations In Pharmacogenomicsmentioning

confidence: 99%

The Role of Pharmacists in Personalised Medicine: A Review of Integrating Pharmacogenomics Into Clinical Practice

Obe Destiny Balogun,

Oluwatoyin Ayo-Farai,

Oluwatosin Ogundairo

et al. 2024

imsrj

View full text Add to dashboard Cite

This paper explores the transformative role of pharmacists in integrating pharmacogenomics into clinical practice. Pharmacogenomics, the study of genetic influences on drug response, presents an unprecedented opportunity to personalise medication management. The pharmacist's role has evolved from medication dispensing to becoming crucial in interpreting and applying genomic data for optimised therapeutic outcomes. We delve into the foundations of pharmacogenomics, historical milestones, and its applications in clinical practice. The pharmacist's responsibilities include interpreting genetic data, collaborating with healthcare providers, counselling patients, and integrating pharmacogenomics into Medication Therapy Management. Challenges, such as ethical considerations and legal frameworks, are navigated to ensure responsible genomic practice. Education emerges as a cornerstone, with recommendations to enhance genomic literacy through comprehensive educational programs. Ethical considerations highlight the importance of informed consent, privacy safeguards, and equitable access to pharmacogenomic information. The future of pharmacogenomics in pharmacy practice relies on interdisciplinary collaboration, continuous education, and ethical adherence, positioning pharmacists as integral contributors to the personalised medicine landscape. Keywords: Pharmacogenomics, Personalised Medicine, Pharmacy Practice, Genomic Literacy, Interdisciplinary Collaboration.

show abstract

Section: Ethical and Legal Considerations In Pharmacogenomicsmentioning

confidence: 99%

The Role of Pharmacists in Personalised Medicine: A Review of Integrating Pharmacogenomics Into Clinical Practice

Obe Destiny Balogun,

Oluwatoyin Ayo-Farai,

Oluwatosin Ogundairo

et al. 2024

imsrj

View full text Add to dashboard Cite

show abstract

“…In the case of data privacy, legislation is in place to protect consumers, and testing providers need to be compliant with these regulations, for example, Health Insurance Portability and Accountability Act (HIPAA), USA; The Personal Information Protection and Electronic Documents Act (PIPE-DA), Bill 6, Canada; and General Data Protection Regulation (GDPR), Europe. 69 Legal liability associated with the use (or failure to use) PGx information when available could also be seen as both a hurdle and motivation of implementation of PGx testing in psychiatry practice.…”

Section: Ethical and Legal Issuesmentioning

confidence: 99%

“…The nontransparency of the future use of data also adds to the fear of data privacy. In the case of data privacy, legislation is in place to protect consumers, and testing providers need to be compliant with these regulations, for example, Health Insurance Portability and Accountability Act (HIPAA), USA; The Personal Information Protection and Electronic Documents Act (PIPEDA), Bill 6, Canada; and General Data Protection Regulation (GDPR), Europe 69 …”

Section: Hurdlesmentioning

confidence: 99%

Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic

Maruf

Bousman

2022

PCN Reports

View full text Add to dashboard Cite

Pharmacogenetic (PGx) testing has emerged as a tool for predicting a person's ability to process and react to drugs. Despite the growing evidence‐base, enthusiasm, and successful efforts to implement PGx testing in psychiatry, a consensus on how best to implement PGx testing into practice has not been established and numerous hurdles to widespread adoption remain to be overcome. In this article, we summarize the most used approaches and commonly encountered hurdles when implementing PGx testing into routine psychiatric care. We also highlight effective strategies that have been used to overcome hurdles. These strategies include the development of user‐friendly clinical workflows for test ordering, use, and communication of results, establishment of test standardization and reimbursement policies, and development of tailored curriculums for educating health‐care providers and the public. Although knowledge and awareness of these approaches and strategies to overcome hurdles alone may not be sufficient for successful implementation, they are necessary to ensure the effective spread, scale, and sustainability of PGx testing in psychiatry and other areas of medicine.

show abstract

The Ethical, Legal, and Regulatory Issues Associated with Pharmacogenomics

Cited by 2 publications

References 18 publications

The Role of Pharmacists in Personalised Medicine: A Review of Integrating Pharmacogenomics Into Clinical Practice

The Role of Pharmacists in Personalised Medicine: A Review of Integrating Pharmacogenomics Into Clinical Practice

Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic

Contact Info

Product

Resources

About